Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

December 16, 2025 — ABIVAX Société Anonyme (listed as ABVX on Euronext Paris and Nasdaq) is back in the spotlight today after publishing third-quarter 2025 financial results and reiterating a long cash runway—news that didn’t stop the stock from pulling
Oceaneering International (OII) Stock News Today: Why Shares Fell on Dec. 16, 2025 — Forecasts, Analyst Targets, and What Investors Are Watching

Oceaneering International (OII) Stock News Today: Why Shares Fell on Dec. 16, 2025 — Forecasts, Analyst Targets, and What Investors Are Watching

Oceaneering International, Inc. (NYSE: OII) stock slid sharply on Tuesday, December 16, 2025, a move that put the offshore-technology and subsea robotics specialist back in the spotlight after a choppy stretch in recent sessions. In afternoon trading, OII was around
Globalstar (GSAT) Stock News on Dec. 16, 2025: Deutsche Bank Starts Coverage, Skydio Drone Trial, and Updated Analyst Forecasts

Globalstar (GSAT) Stock News on Dec. 16, 2025: Deutsche Bank Starts Coverage, Skydio Drone Trial, and Updated Analyst Forecasts

Globalstar, Inc. stock (NASDAQ: GSAT) traded sharply lower on Tuesday, December 16, 2025, despite fresh operational news highlighting its licensed spectrum and private 5G ambitions. Shares were down about 8.5% at $63.20 in the latest trading update (after opening near
Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics Incorporated (NASDAQ: CORT) ended Tuesday, December 16, 2025, sharply lower after a strong 2025 run that had pushed expectations—and valuation—into the spotlight. Shares closed at $79.44, down $7.86 (about 9%) from the prior close, after trading as low
1 335 336 337 338 339 577
Go toTop